Keywords: patent, expiries, stall, bph, drug, sales, during

Patent expiries "will stall BPH drug sales during 2007-12"

Article | 29 September 2003

Print This

Patent expiries on drugs to treat benign prostatic hyperplasia will impact sales in all major markets (France, Germany, Italy, Japan, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in